Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 329

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases

Open access
Raman, Sudha R, Man, Kenneth K C, Bahmanyar, Shahram, Berard, Anick, Bilder, Scott, Boukhris, Takoua, Bushnell, Greta, Crystal, Stephen, Furu, Kari, KaoYang, Yea-Huei, Karlstad, Øystein, Kieler, Helle, Kubota, Kiyoshi, Lai, Edward Chia-Cheng, Martikainen, Jaana E, Maura, Géric, Moore, Nicholas, Montero, Dolores, Nakamura, Hidefumi, Neumann, Anke, Pate, Virginia, Pottegård, Anton, Pratt, Nicole L, Roughead, Elizabeth E, Macias Saint-Gerons, Diego, Stürmer, Til, Su, Chien-Chou, Zoega, Helga, Sturkenbroom, Miriam C J M, Chan, Esther W, Coghill, David, Ip, Patrick, Wong, Ian C K·2018·The Lancet Psychiatry

Abstract

BACKGROUND The use of medications to treat attention deficit hyperactivity disorder (ADHD) has increased, but the prevalence of ADHD medication use across different world regions is not known. Our objective was to determine regional and national prevalences of ADHD medication use in children and adults, with a specific focus on time trends in ADHD medication prevalence. METHODS We did a retrospective, observational study using population-based databases from 13 countries and one Special Administrative Region (SAR): four in Asia and Australia, two in North America, five in northern Europe, and three in western Europe. We used a common protocol approach to define study populations and parameters similarly across countries and the SAR. Study populations consisted of all individuals aged 3 years or older between Jan 1, 2001, and Dec 31, 2015 (dependent on data availability). We estimated annual prevalence of ADHD medication use with 95% CI during the study period, by country and region and stratified by age and sex. We reported annual absolute and relative percentage changes to describe time trends. FINDINGS 154·5 million individuals were included in the study. ADHD medication use prevalence in 2010 (in children aged 3-18 years) varied between 0·27% and 6·69% in the countries and SAR assessed (0·95% in Asia and Australia, 4·48% in North America, 1·95% in northern Europe, and 0·70% in western Europe). The prevalence of ADHD medication use among children increased over time in all countries and regions, and the absolute increase per year ranged from 0·02% to 0·26%. Among adults aged 19 years or older, the prevalence of any ADHD medication use in 2010 varied between 0·003% and 1·48% (0·05% in Asia and Australia, 1·42% in North America, 0·47% in northern Europe, and 0·03% in western Europe). The absolute increase in ADHD medication use prevalence per year ranged from 0·0006% to 0·12%. Methylphenidate was the most commonly used ADHD medication in most countries. INTERPRETATION Using a common protocol and data from 13 countries and one SAR, these results show increases over time but large variations in ADHD medication use in multiple regions. The recommendations of evidence-based guidelines need to be followed consistently in clinical practice. Further research is warranted to describe the safety and effectiveness of ADHD medication in the short and long term, and to inform evidence-based guidelines, particularly in adults. FUNDING None.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2215-0366(18)30293-1

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Cited by

See all 329

Metadata

Authors
Raman, S. R., Man, K. K. C., Bahmanyar, S., Berard, A., Bilder, S., Boukhris, T., Bushnell, G., Crystal, S., Furu, K., KaoYang, Y.-H., Karlstad, Ø., Kieler, H., Kubota, K., Lai, E. C.-C., Martikainen, J. E., Maura, G., Moore, N., Montero, D., Nakamura, H., Neumann, A., Pate, V., Pottegård, A., Pratt, N. L., Roughead, E. E., Macias Saint-Gerons, D., Stürmer, T., Su, C.-C., Zoega, H., Sturkenbroom, M. C. J. M., Chan, E. W., Coghill, D., Ip, P., & Wong, I. C. K.
Venue
The Lancet Psychiatry
Publisher
Elsevier BV
Published
2018-10
Volume
5
Issue
10
Pages
824-835
ISSN
2215-0366 (ISSN-L)
OpenAlex
W2890361884
Cited by
329
References
32
FWCI
19.42
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases. https://app.cochat.ai/papers/10.1016/s2215-0366(18)30293-1
The paper
Raman, S. R., Man, K. K. C., Bahmanyar, S., Berard, A., Bilder, S., Boukhris, T., Bushnell, G., Crystal, S., Furu, K., KaoYang, Y.-H., Karlstad, Ø., Kieler, H., Kubota, K., Lai, E. C.-C., Martikainen, J. E., Maura, G., Moore, N., Montero, D., Nakamura, H., . . . Wong, I. C. K. (2018). Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases. The Lancet Psychiatry. https://doi.org/10.1016/s2215-0366(18)30293-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.